Can drug price hikes via debranding be prevented?
Tools
Bokhari, Farasat and Lyons, Bruce (2017) Can drug price hikes via debranding be prevented? Prescriber, 28 (4). pp. 44-46.
![]()
|
PDF (Accepted manuscript)
- Accepted Version
Download (175kB) | Preview |
Abstract
Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?
Item Type: | Article |
---|---|
Faculty \ School: | Faculty of Social Sciences > School of Economics |
Related URLs: | |
Depositing User: | Pure Connector |
Date Deposited: | 12 May 2017 05:05 |
Last Modified: | 04 Apr 2021 01:11 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/63483 |
DOI: | 10.1002/psb.1563 |
Actions (login required)
![]() |
View Item |